OrigynMed
Hangzhou, China · $15.3M raised
- Headquarters
- Hangzhou
- Business Model
- B2B
- Website
- origynmed.com
- Total Funding
- $15.3M
- Last Round
- $15.3M Extension RoundJan 2022
- Rounds
- 3
About
OrigynMed (英姿医疗) was founded by veteran healthcare entrepreneurs previously behind TCT Medical, a company known for advancing cervical cancer screening and prevention in China. The Hangzhou-based women's health company has attracted top investors including Eight Roads, Sequoia China, and Lilly Asia, and aims to build a respected innovative medical platform enterprise so women can equally benefit from medical innovation.
Summary
OrigynMed is a Biotech company based in Hangzhou, China. It has raised $15.3M in total across 3 rounds, most recently a $15.3M Extension Round round in Jan 2022. Investors include Eight Roads Ventures, Lilly Asia Ventures and F-Prime Capital.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...